Takara Bio Inc. (TYO:4974)
Japan flag Japan · Delayed Price · Currency is JPY
1,146.00
-1.00 (-0.09%)
At close: Mar 6, 2026

Takara Bio Revenue

Takara Bio had revenue of 9.60B JPY in the quarter ending December 31, 2025, with 0.78% growth. This brings the company's revenue in the last twelve months to 44.15B, up 2.55% year-over-year. In the fiscal year ending March 31, 2025, Takara Bio had annual revenue of 45.04B with 3.53% growth.

Revenue (ttm)
44.15B
Revenue Growth
+2.55%
P/S Ratio
3.13
Revenue / Employee
24.82M
Employees
1,779
Market Cap
138.00B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202545.04B1.53B3.53%
Mar 31, 202443.51B-34.64B-44.33%
Mar 31, 202378.14B10.44B15.43%
Mar 31, 202267.70B21.61B46.90%
Mar 31, 202146.09B11.52B33.33%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Nxera Pharma29.62B
GNI Group26.84B
PeptiDream18.52B
RaQualia Pharma3.98B
Japan Tissue Engineering2.26B
AnGes874.00M
Cuorips356.00M
Renascience107.00M
Revenue Rankings